
PRECIGEN, INC. — Investor Relations & Filings
Precigen, Inc. is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation gene and cell therapies. The company utilizes precision technology to create highly targeted medicines for difficult-to-treat diseases. Its primary therapeutic areas of focus include immuno-oncology and autoimmune disorders. Precigen aims to provide innovative treatments for patients with significant unmet medical needs by advancing its portfolio of precision medicines.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - PRECIGEN, INC. (0001356090) (Filer) | 2026-04-30 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 39209630 | ARS - PRECIGEN, INC. (0001356090) (Filer) | 2026-04-30 | English | ||
| 33003256 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003253 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003251 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003245 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003240 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 29056442 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 29056636 | SCHEDULE 13G Filing | 2026-01-23 | English | ||
|
2025
7 filings
| |||||
| 11953822 | PRIMARY DOCUMENT | 2025-12-23 | English | ||
| 11953825 | Regulatory Filings 2025 | 2025-12-23 | English | ||
| 11953823 | FORM 4 | 2025-12-16 | English | ||
| 11953826 | Regulatory Filings 2025 | 2025-12-13 | English | ||
| 11953828 | Major Shareholding Notification 2025 | 2025-11-22 | English | ||
| 11953827 | PRIMARY DOCUMENT | 2025-11-22 | English | ||
| 11953829 | Regulatory Filings 2025 | 2025-11-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
|
Ambrilia Biopharma Inc.
Biopharmaceutical company focused on novel treatments for o…
|
AMB | CA | Manufacturing |
|
AMGEN INC
A biotechnology company developing human therapeutics for s…
|
AMGN | US | Manufacturing |
|
Amicogen, Inc.
Industrial biotechnology company specializing in specialty …
|
092040 | KR | Manufacturing |
PRECIGEN, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32044/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32044 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32044 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32044 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32044}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PRECIGEN, INC. (id: 32044)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.